Mar 5
|
FDA Lifts Clinical Hold on Iovance's (IOVA) Lung Cancer Study
|
Mar 4
|
J&J (JNJ) Secures Full FDA Nod for Rybrevant in Lung Cancer
|
Feb 14
|
Zacks Industry Outlook Highlights Sarepta, Exelixis, Immunocore, Editas and Puma Biotechnology
|
Feb 13
|
Puma Biotechnology Announces Initiation of ALISCA-Lung1 Phase II Trial of Alisertib in Small Cell Lung Cancer
|
Feb 12
|
Humacyte (HUMA) Up on HAV BLA Priority Tag for Vascular Trauma
|
Jan 19
|
Mesoblast (MESO) Up on Rare Pediatric Disease Tag for Heart Drug
|
Jan 19
|
Exelixis (EXEL) Reports Positive EU Patent Ruling for Cabometyx
|
Jan 19
|
Syros (SYRS) Stock Surges 200% in 3 Months: Here's Why
|
Jan 19
|
Vor Bio (VOR) Up on Positive Update From AML Cell Therapy Study
|
Jan 18
|
Instil (TIL) Stock Rises More Than 20% in a Week: Here's Why
|
Jan 17
|
Solid Biosciences' (SLDB) DMD Drug Gets Orphan Tag, Stock Up
|
Jan 17
|
Aclaris (ACRS) Stock Rises on Appointment of New Interim CEO
|
Jan 17
|
Annexon (ANNX) Stock Rallies 156% in 3 Months: Here's How
|
Jan 16
|
IGM Bio (IGMS) Stock Rallies 142% in 3 Months: Here's Why
|
Jan 15
|
Adicet (ACET) Stock Rallies 130% in a Month: Here's Why
|
Jan 15
|
Solid Biosciences (SLDB) Rises 271% in 3 Months: Here's Why
|
Jan 12
|
Amicus (FOLD) Stock Rises More Than 25% in 3 Months: Here's Why
|
Jan 11
|
Puma Biotechnology to Present at B. Riley Securities 4th Annual Oncology Conference
|
Jan 11
|
Amarin (AMRN) Stock Rises on Stellar Q4 Preliminary Results
|
Jan 11
|
Mirati (MRTX) Gets EU Nod for Krazati in KRAS-Mutated NSCLC
|